I’m 57 with a $1.5M home and a $400K rental with a 7.4% mortgage. I’m getting a $375K check soon. My financial adviser told ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

This was the stock's second consecutive day of losses.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $307.44, ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Humana has gotten torched over the last six months - since November 2024, its stock price has dropped 24.3% to a new 52-week ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Enphase Energy (ENPH) was the worst-performing stock in the S&P 500 ... in well below estimates on falling gas prices. Shares of Humana (HUM) and other health insurance providers declined as ...

Shares of Humana and other health insurance providers ... Enphase Energy (ENPH) was the worst-performing stock in the S&P 500, and shares of rivals in the solar sector were also down, as the ...

Given Humana's weak financial performance since 2023 due to a mismatch in rates and utilization in MA and the potential for low MA bonus payments in 2026 due to weak star ratings, a major cash ...